Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
Yan Wang, Haiqing Ni, Shuaixiang Zhou, Kaijie He, Yarong Gao, Weiwei Wu, Min Wu, Zhihai Wu, Xuan Qiu, Ying Zhou, Bingliang Chen, Donghui Pan, Chenrong Huang, Mingzhu Li, Yicong Bian, Min Yang, Liyan Miao, Junjian Liu
Topics & Concepts
CD47BlockadeImmune systemPhagocytosisAntibodyCancer researchMonoclonal antibodyImmunotherapyImmune checkpointCancer immunotherapyInnate immune systemCancer cellIn vivoImmunologyReceptorCancerBiologyMedicineInternal medicineBiochemistryBiotechnologyPhagocytosis and Immune RegulationExtracellular vesicles in diseaseErythrocyte Function and Pathophysiology